Skip to main content
. 2019 Dec 11;6(4):112. doi: 10.3390/bioengineering6040112

Figure 1.

Figure 1

Percentage increase (mean ± standard deviation) in cytotoxicity of AESN (concentration: 5 g/L and 10 g/L) against human mammary gland epithelial cell line MCF12A and breast cancer cell line MCF7. The cytotoxicity was measured 72 h of treatment using the CytoTox 96 Non-radioactive Cytotoxicity Assay. Cells treated with water were used as a negative control.